(S2O-12146) Omacor is one of a number of potential treatments for the secondary prevention of myocardial infarction.The Scottish medicines consortium has advised that it is acceptable for general use by NHS Scotland, but a number of alternatives already exist and its implementation is therefore a matter for each local national health service board.